Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Director departure
Appointed director
Notes underwriting agrmnt
SANUWAVE Health, Inc. (SNWV) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "SANUWAVE Health, Inc. , a leading provider of next-generation FDA-approved wound care products, today announced that revenues for the third quarter of 2023 are expected to be in the range of $4.7 to $4.9 million."
08/23/2023 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among SEP Acquisition Corp., SEP Acquisition Holdings Inc., and SANUWAVE Health, Inc",
"Form of Voting Agreement, by and among SEP Acquisition Corp., SANUWAVE Health, Inc., and the stockholder of SANUWAVE Health, Inc. party thereto",
"Sponsor Voting Agreement, by and among Mercury Sponsor Group I LLC, SEP Acquisition Corp., and SANUWAVE Health, Inc",
"Form of Lock-Up Agreement, by and between SEP Acquisition Corp. and the stockholder of SANUWAVE Health, Inc. party thereto",
"Exhibit 99.1"
08/11/2023 8-K Quarterly results
07/31/2023 8-K Quarterly results
07/26/2023 8-K Quarterly results
07/19/2023 8-K Quarterly results
06/29/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Fourth Amendment to Note and Warrant Purchase and Security Agreement, by and among the Company, the noteholder party thereto and NH Expansion Credit Fund Holdings LP, as agent"
05/12/2023 8-K Quarterly results
Docs: "Sanuwave announces Q1 2023 financial results"
04/03/2023 8-K Quarterly results
Docs: "Recent Developments and Upcoming Events"
03/31/2023 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review &nbsp...
11/14/2022 8-K Quarterly results
Docs: "Press Release",
"Eden Prairie, MN, August 15, 2022 - SANUWAVE Health, Inc. a leading provider of next-generation wound care products, reported financial results for their second quarter, ending June 30, 2022, with the SEC on Friday, August 12, 2022. The Company will host a live conference call on Tuesday August 16, 2022, at 12:30 to provide a business update . Quarter Highlights: - Over 50 systems placed to treat wounds o 100% increase from the 25 systems placed Q2 2021 - Over 40,000 wound treatments administered o Up from 31,000 treatments administered Q2 2021 - Successfully completed MDSAP audit - Transitioned company from Suwanee GA to Eden Prairie MN - Became current on SEC filings - Launched Cosmetic and Orthopedics verticals with initial sales in each “Our key ENERGY FIRST products, dermaPACE® and Ul..."
10/13/2022 8-K Investor presentation
Docs: "Investor Presentation"
08/19/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
07/07/2022 8-K Quarterly results
04/15/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Ian Miller: Commercial Vice President of Hoogwegt US where he manages a team of traders generating more than $500 Million in annual revenue by purchasing and selling in excess of 250,000 metric tons of commodities which are distributed around the globe. Mr. Miller has a Master of Business Administration from Drake University and brings over 20 years of sales leadership knowledge that will help SANUWAVE develop its non-medical verticals and growth strategies. Throughout his career, Mr. Miller has built a successful track record for business development and strategic implementation that have helped companies grow both their top and bottom lines."
03/02/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
10/01/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/28/2021 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
09/14/2021 8-K Quarterly results
07/01/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/07/2021 8-K Quarterly results
04/27/2021 8-K Quarterly results
02/18/2021 8-K Quarterly results
01/05/2021 8-K Quarterly results
08/12/2020 8-K Quarterly results
08/12/2020 8-K Quarterly results
08/12/2020 8-K Quarterly results
08/07/2020 8-K Quarterly results
07/24/2020 8-K Quarterly results
06/11/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "SECURITIES PURCHASE AGREEMENT",
"CONVERTIBLE PROMISSORY NOTE",
"COMMON STOCK PURCHASE WARRANT"
06/10/2020 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "SANUWAVE HEALTH ENTERS INTO EXCLUSIVE LETTER OF INTENT TO ACQUIRE CELULARITY’S ULTRAMIST® AND EXCLUSIVE PARTNERSHIP RIGHTS FOR WOUND CARE BIOLOGIC PRODUCTS Contemplated Transaction Would Create a Leading Provider of Advanced Wound Care Solutions that Improve Clinical Outcomes Across the Continuum of Care SUWANEE, GA, June 10, 2020 - SANUWAVE Health, Inc. today announced that it has entered into an exclusive, non-binding letter of intent to acquire Celularity’s UltraMIST® Ultrasound Healing Therapy asset as well as exclusive partnership rights for Celularity’s wound care biologic products. Celularity is a privately held, clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies, engineered from the postpartum human placenta, in cancer, infect..."
06/01/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy